Literature DB >> 15095042

Is "Cushing's disease of the omentum" an affliction of mouse and men?

B R Walker1.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15095042     DOI： 10.1007/s00125-004-1390-y

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  27 in total

1.  Does central obesity reflect "Cushing's disease of the omentum"?

Authors:  I J Bujalska; S Kumar; P M Stewart
Journal:  Lancet       Date:  1997-04-26       Impact factor: 79.321

2.  Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice.

Authors:  Nicholas M Morton; Janice M Paterson; Hiroaki Masuzaki; Megan C Holmes; Bart Staels; Catherine Fievet; Brian R Walker; Jeffrey S Flier; John J Mullins; Jonathan R Seckl
Journal:  Diabetes       Date:  2004-04       Impact factor: 9.461

3.  Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice.

Authors:  N M Morton; M C Holmes; C Fiévet; B Staels; A Tailleux; J J Mullins; J R Seckl
Journal:  J Biol Chem       Date:  2001-08-23       Impact factor: 5.157

4.  Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation.

Authors:  B R Walker; A A Connacher; R M Lindsay; D J Webb; C R Edwards
Journal:  J Clin Endocrinol Metab       Date:  1995-11       Impact factor: 5.958

5.  Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice.

Authors:  Hiroaki Masuzaki; Hiroshi Yamamoto; Christopher J Kenyon; Joel K Elmquist; Nicholas M Morton; Janice M Paterson; Hiroshi Shinyama; Matthew G F Sharp; Stewart Fleming; John J Mullins; Jonathan R Seckl; Jeffrey S Flier
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

6.  Polyglandular autoimmune syndromes: immunogenetics and long-term follow-up.

Authors:  Manuela Dittmar; George J Kahaly
Journal:  J Clin Endocrinol Metab       Date:  2003-07       Impact factor: 5.958

7.  Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver.

Authors:  Jukka Westerbacka; Hannele Yki-Järvinen; Satu Vehkavaara; Anna-Maija Häkkinen; Ruth Andrew; Deborah J Wake; Jonathan R Seckl; Brian R Walker
Journal:  J Clin Endocrinol Metab       Date:  2003-10       Impact factor: 5.958

8.  Mineralocorticoid excess and inhibition of 11 beta-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome.

Authors:  B R Walker; J C Campbell; R Fraser; P M Stewart; C R Edwards
Journal:  Clin Endocrinol (Oxf)       Date:  1992-12       Impact factor: 3.478

9.  Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians.

Authors:  Robert S Lindsay; Deborah J Wake; Saraswathy Nair; Joy Bunt; Dawn E W Livingstone; Paska A Permana; P Antonio Tataranni; Brian R Walker
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

10.  Portal and peripheral cortisol levels in obese humans.

Authors:  W Aldhahi; E Mun; A B Goldfine
Journal:  Diabetologia       Date:  2004-04-17       Impact factor: 10.122
View more
  5 in total

1.  Hepatic 11β-hydroxysteroid dehydrogenase type 1 activity in obesity and type 2 diabetes using a novel triple tracer cortisol technique.

Authors:  Simmi Dube; Barbara Norby; Vishwanath Pattan; Ravi K Lingineni; Ravinder J Singh; Rickey E Carter; Ananda Basu; Rita Basu
Journal:  Diabetologia       Date:  2014-04-26       Impact factor: 10.122

2.  Liver is the site of splanchnic cortisol production in obese nondiabetic humans.

Authors:  Rita Basu; Ananda Basu; Meagan Grudzien; Paul Jung; Peer Jacobson; Michael Johnson; Ravinder Singh; Michael Sarr; Robert A Rizza
Journal:  Diabetes       Date:  2008-10-13       Impact factor: 9.461

3.  11β-hydroxysteroid dehydrogenase types 1 and 2 activity in subcutaneous adipose tissue in humans: implications in obesity and diabetes.

Authors:  Simmi Dube; Barbara J Norby; Vishwanath Pattan; Rickey E Carter; Ananda Basu; Rita Basu
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

4.  Increased Cortisol and Cortisone Levels in Overweight Children.

Authors:  Lanling Chu; Kangwei Shen; Ping Liu; Kan Ye; Yu Wang; Chen Li; Xuejun Kang; Yuan Song
Journal:  Med Sci Monit Basic Res       Date:  2017-02-09

Review 5.  11β-HSD as a New Target in Pharmacotherapy of Metabolic Diseases.

Authors:  Daria Kupczyk; Rafał Bilski; Mariusz Kozakiewicz; Renata Studzińska; Kornelia Kędziora-Kornatowska; Tomasz Kosmalski; Agnieszka Pedrycz-Wieczorska; Mariola Głowacka
Journal:  Int J Mol Sci       Date:  2022-08-11       Impact factor: 6.208
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.